![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Plcxd1 | Rat | (-)-demecolcine | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of PLCXD1 mRNA | CTD | PMID:23649840 | Plcxd1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Plcxd1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLCXD1 mRNA | CTD | PMID:21570461 and PMID:26377647 | Plcxd1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Plcxd1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLCXD1 mRNA | CTD | PMID:19770486 and PMID:26290441 | Plcxd1 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of PLCXD1 mRNA | CTD | PMID:30851411 | Plcxd1 | Rat | 2-methylcholine | affects expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of PLCXD1 mRNA | CTD | PMID:21179406 | Plcxd1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of PLCXD1 mRNA | CTD | PMID:27685785 | Plcxd1 | Rat | all-trans-retinoic acid | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of PLCXD1 mRNA | CTD | PMID:21934132 and PMID:33167477 | Plcxd1 | Rat | arsenous acid | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of PLCXD1 mRNA | CTD | PMID:20458559 | Plcxd1 | Rat | benzo[a]pyrene | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of PLCXD1 mRNA | CTD | PMID:26238291 and PMID:32234424 | Plcxd1 | Rat | beta-damascenone | increases expression | ISO | Plcxd1 (Mus musculus) | 6480464 | beta-damascenone results in increased expression of PLCXD1 mRNA | CTD | PMID:22982537 | Plcxd1 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of PLCXD1 mRNA | CTD | PMID:25181051 | Plcxd1 | Rat | butan-1-ol | multiple interactions | ISO | PLCXD1 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLCXD1 mRNA | CTD | PMID:29432896 | Plcxd1 | Rat | butanal | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of PLCXD1 mRNA | CTD | PMID:26079696 | Plcxd1 | Rat | cadmium atom | multiple interactions | ISO | PLCXD1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLCXD1 mRNA | CTD | PMID:35301059 | Plcxd1 | Rat | cadmium dichloride | multiple interactions | ISO | PLCXD1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLCXD1 mRNA | CTD | PMID:35301059 | Plcxd1 | Rat | carbon nanotube | increases expression | ISO | Plcxd1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Plcxd1 | Rat | ciglitazone | multiple interactions | ISO | PLCXD1 (Homo sapiens) | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLCXD1 mRNA | CTD | PMID:16197558 | Plcxd1 | Rat | coumestrol | multiple interactions | ISO | PLCXD1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLCXD1 mRNA | CTD | PMID:19167446 | Plcxd1 | Rat | dexamethasone | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of PLCXD1 mRNA | CTD | PMID:25047013 | Plcxd1 | Rat | diallyl trisulfide | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | diallyl trisulfide results in increased expression of PLCXD1 mRNA | CTD | PMID:34995734 | Plcxd1 | Rat | diarsenic trioxide | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of PLCXD1 mRNA | CTD | PMID:20458559 | Plcxd1 | Rat | Dibutyl phosphate | affects expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of PLCXD1 mRNA | CTD | PMID:37042841 | Plcxd1 | Rat | dicrotophos | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of PLCXD1 mRNA | CTD | PMID:28302478 | Plcxd1 | Rat | diquat | increases expression | ISO | Plcxd1 (Mus musculus) | 6480464 | Diquat results in increased expression of PLCXD1 mRNA | CTD | PMID:36851058 | Plcxd1 | Rat | doxorubicin | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of PLCXD1 mRNA | CTD | PMID:29803840 | Plcxd1 | Rat | Enterolactone | multiple interactions | ISO | PLCXD1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLCXD1 mRNA | CTD | PMID:19167446 | Plcxd1 | Rat | ethanol | multiple interactions | ISO | PLCXD1 (Homo sapiens) | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLCXD1 mRNA | CTD | PMID:29432896 | Plcxd1 | Rat | gallic acid | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Gallic Acid results in decreased expression of PLCXD1 mRNA | CTD | PMID:34408198 | Plcxd1 | Rat | hydroquinone | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | hydroquinone results in increased expression of PLCXD1 mRNA | CTD | PMID:31256213 | Plcxd1 | Rat | Licochalcone B | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | licochalcone B results in increased expression of PLCXD1 mRNA | CTD | PMID:33647349 | Plcxd1 | Rat | methotrexate | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of PLCXD1 mRNA | CTD | PMID:17400583 and PMID:24449571 | Plcxd1 | Rat | nickel sulfate | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of PLCXD1 mRNA | CTD | PMID:22714537 | Plcxd1 | Rat | O-methyleugenol | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of PLCXD1 mRNA | CTD | PMID:32234424 | Plcxd1 | Rat | perfluorononanoic acid | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of PLCXD1 mRNA | CTD | PMID:32588087 | Plcxd1 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of PLCXD1 mRNA | CTD | PMID:32588087 | Plcxd1 | Rat | potassium chromate | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of PLCXD1 mRNA | CTD | PMID:22714537 | Plcxd1 | Rat | quercetin | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Quercetin results in increased expression of PLCXD1 mRNA | CTD | PMID:30152185 | Plcxd1 | Rat | rac-lactic acid | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of PLCXD1 mRNA | CTD | PMID:30851411 | Plcxd1 | Rat | sodium arsenite | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of PLCXD1 mRNA | CTD | PMID:28595984 | Plcxd1 | Rat | sodium arsenite | affects expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of PLCXD1 mRNA | CTD | PMID:34032870 | Plcxd1 | Rat | sodium arsenite | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of PLCXD1 mRNA | CTD | PMID:29301061 | Plcxd1 | Rat | sunitinib | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of PLCXD1 mRNA | CTD | PMID:31533062 | Plcxd1 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of PLCXD1 mRNA | CTD | PMID:34492290 | Plcxd1 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of PLCXD1 mRNA | CTD | PMID:33387578 | Plcxd1 | Rat | Triptolide | decreases expression | ISO | Plcxd1 (Mus musculus) | 6480464 | triptolide results in decreased expression of PLCXD1 mRNA | CTD | PMID:32835833 | Plcxd1 | Rat | triptonide | decreases expression | ISO | Plcxd1 (Mus musculus) | 6480464 | triptonide results in decreased expression of PLCXD1 mRNA | CTD | PMID:33045310 | Plcxd1 | Rat | trovafloxacin | increases expression | ISO | Plcxd1 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of PLCXD1 mRNA | CTD | PMID:35537566 | Plcxd1 | Rat | valproic acid | increases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of PLCXD1 mRNA | CTD | PMID:29154799 | Plcxd1 | Rat | vincristine | decreases expression | ISO | PLCXD1 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of PLCXD1 mRNA | CTD | PMID:23649840 | |